Clinical Trials Browser

Phase 1/2 × Terminated × dactolisib × Clear all

NCT01495247 2020-12-08

Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT01453595 2016-02-29

BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)

Phase 1/2 Terminated

10 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms